Catalyst Wire Dossier Catalyst Wire Dossier

Rivastigmine Transdermal Patch

rivastigmine · Zodiac Produtos Farmaceuticos S.A.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Rivastigmine Transdermal Patch, covering 2017-02-23 to 2026-03-11. Get the full timeline:

Most recent: Clinical Trial Update: Rivastigmine Transdermal Patches Bioequivalence and Adhesion Assessment [Phase 1]

See pricing